James Miser - Net Worth and Insider Trading

James Miser Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, James Miser owns 1 companies in total, including Lixte Biotechnology Holdings Inc (LIXT) .

Click here to see the complete history of James Miser’s form 4 insider trades.

Insider Ownership Summary of James Miser

Ticker	Comapny	Transaction Date	Type of Owner
LIXT	Lixte Biotechnology Holdings Inc	2020-08-01	Chief Medical Officer

James Miser Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

James Miser Ownership Network

Ownership Network List of James Miser

No Data

Ownership Network Relation of James Miser

James Miser Owned Company Details

What does Lixte Biotechnology Holdings Inc do?

Who are the key executives at Lixte Biotechnology Holdings Inc?

James Miser is the Chief Medical Officer of Lixte Biotechnology Holdings Inc. Other key executives at Lixte Biotechnology Holdings Inc include 10 percent owner Eric Forman , 10 percent owner Glenn Krinsky , and 10 percent owner Robert Greenberg .

Lixte Biotechnology Holdings Inc (LIXT) Insider Trades Summary

Over the past 18 months, James Miser made no insider transaction in Lixte Biotechnology Holdings Inc (LIXT). Other recent insider transactions involving Lixte Biotechnology Holdings Inc (LIXT) include a net purchase of 45,000 shares made by Rene Bernards , a net purchase of 16,112 shares made by Eric Forman , and a net purchase of 10,000 shares made by Van Der Baan Bastiaan Jeroen .

In summary, during the past 3 months, insiders sold 0 shares of Lixte Biotechnology Holdings Inc (LIXT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lixte Biotechnology Holdings Inc (LIXT) were sold and 34,111 shares were bought by its insiders, resulting in a net purchase of 34,111 shares.

Lixte Biotechnology Holdings Inc (LIXT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Lixte Biotechnology Holdings Inc Insider Transactions

No Available Data

James Miser Mailing Address

Above is the net worth, insider trading, and ownership report for James Miser. You might contact James Miser via mailing address: 680 E Colorado Blvd., Suite 180, Pasadena Ca 91101.

Discussions on James Miser

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.